Publication | Open Access
Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma
55
Citations
39
References
2016
Year
ClinicalTrials.gov NCT01310855.
| Year | Citations | |
|---|---|---|
Page 1
Page 1